Effect of hypolipidemic drugs, nafenopin and clofibrate, on the concentration of ligandin and Z protein in rat liver
- 15 December 1975
- journal article
- Published by Elsevier BV in Biochemical and Biophysical Research Communications
- Vol. 67 (4), 1401-1407
- https://doi.org/10.1016/0006-291x(75)90182-5
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- Z protein in hepatic uptake and esterification of long-chain fatty acidsAmerican Journal of Physiology-Legacy Content, 1975
- Studies on the hepatomegaly caused by the hypolipidemic drugs nafenopin and clofibrateToxicology and Applied Pharmacology, 1972
- A Binding Protein for Fatty Acids in Cytosol of Intestinal Mucosa, Liver, Myocardium, and Other TissuesScience, 1972
- The binding of fatty acids to cytoplasmic proteins: Binding to Z protein in liver and other tissues of the ratBiochemical and Biophysical Research Communications, 1972
- Studies of Y and Z, two hepatic cytoplasmic organic anion-binding proteins: effect of drugs, chemicals, hormones, and cholestasisJCI Insight, 1971
- Phylogenetic Study of Organic Anion Transfer from Plasma into the LiverNature New Biology, 1971
- Two hepatic cytoplasmic protein fractions, Y and Z, and their possible role in the hepatic uptake of bilirubin, sulfobromophthalein, and other anionsJCI Insight, 1969
- Hypolipidaemic properties of a new tetralin derivative (CIBA 13,437-Su)Cellular and Molecular Life Sciences, 1968
- Changes in the weight and composition of the liver in the rat, dog and monkey treated with ethyl chlorophenoxyisobutyrateBiochemical Pharmacology, 1966
- NATURE OF THE HEPATOMEGALIC EFFECT PRODUCED BY ETHYL-CHLOROPHENOXY-ISOBUTYRATE IN THE RATNature, 1965